NEOG · Company research

Neogen Corp (NEOG): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

27records availableHealthcare

Stock News & Events data

Database-backed records only

27 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Neogen Corporation (NEOG) Stock forecasts - Yahoo Finance UKNeogen Corporation (NEOG) Stock forecasts Yahoo Finance UKView source ↗Yahoo Finance UKOct 17, 2026neutral00.6
Neogen Corporation (NEOG) Stock Forecasts - Yahoo! Finance CanadaNeogen Corporation (NEOG) Stock Forecasts Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 17, 2026neutral00.6
Neogen Corporation (NEOG) Stock Forecasts - Yahoo FinanceNeogen Corporation (NEOG) Stock Forecasts Yahoo FinanceView source ↗Yahoo FinanceOct 14, 2026neutral00.6
Neogen (NEOG) Stock Dropped, So What Is Driving Attention Now? - Simply Wall StreetNeogen (NEOG) Stock Dropped, So What Is Driving Attention Now? Simply Wall StreetView source ↗Simply Wall StreetOct 14, 2026neutral00.6
Neogen Corporation (NEOG) stock price, news, quote and history - Yahoo Finance SingaporeNeogen Corporation (NEOG) stock price, news, quote and history Yahoo Finance SingaporeView source ↗Yahoo Finance SingaporeOct 13, 2026neutral00.6
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOGThe FDA issued a warning letter to Neogen Corporation on September 29, 2026, following an investigation linking its veterinary wound care product Neogen Vet HYCOAT to at least 20 horse deaths from serious infections. The contaminated sterile solution represents the largest number of horse deaths associated with a quality defect in an FDA-regulated veterinary product. Neogen initiated a voluntary recall in January 2026. The announcement triggered a 7.22% stock price decline. Pomerantz LLP is investigating potential securities fraud claims on behalf of investors.View source ↗GlobeNewswire Inc.Oct 13, 2026bearish-11
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOGThe FDA issued a warning letter to Neogen Corporation on September 29, 2026, following an investigation linking its veterinary wound care product Neogen Vet HYCOAT to at least 20 horse deaths from serious infections. The contaminated sterile solution represents the largest number of horse deaths associated with a quality defect in an FDA-regulated veterinary product. Neogen initiated a voluntary recall in January 2026. The announcement triggered a 7.22% stock price decline. Pomerantz LLP is investigating potential securities fraud claims on behalf of investors.View source ↗GlobeNewswire Inc.Oct 13, 2026bearish-11
Understanding Momentum Shifts in (NEOG) - Stock Traders DailyUnderstanding Momentum Shifts in (NEOG) Stock Traders DailyView source ↗Stock Traders DailyOct 13, 2026neutral00.6
Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve CannabisThe Medical Products industry faces moderate growth prospects with resilient healthcare demand offset by tariff pressures and manufacturing costs. ICU Medical shows strong momentum in infusion systems with improving earnings, Neogen benefits from commercial execution improvements in food and animal safety, while Trulieve Cannabis expects growth acceleration from new markets like Georgia and Texas despite Florida seasonal softness.View source ↗Zacks Investment ResearchOct 12, 2026bullish0.6671
Neogen Corporation (NEOG) stock price, news, quote and history - Yahoo Finance UKNeogen Corporation (NEOG) stock price, news, quote and history Yahoo Finance UKView source ↗Yahoo Finance UKOct 10, 2026neutral00.6
Neogen Corporation (NEOG) Stock Price, News, Quote & History - Yahoo! Finance CanadaNeogen Corporation (NEOG) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 10, 2026neutral00.6
FDA Warning Letter Could Be A Game Changer For Neogen Stock (NEOG) - Simply Wall StreetFDA Warning Letter Could Be A Game Changer For Neogen Stock (NEOG) Simply Wall StreetView source ↗Simply Wall StreetOct 10, 2026neutral00.6
Held by his son, 505 shares were bought at $11.95 each, Neogen (NEOG) CEO reports. - Stock TitanHeld by his son, 505 shares were bought at $11.95 each, Neogen (NEOG) CEO reports. Stock TitanView source ↗Stock TitanOct 9, 2026neutral00.6
Neogen (NEOG) Received An FDA Warning Over Contaminated Veterinary Product - Yahoo FinanceNeogen (NEOG) Received An FDA Warning Over Contaminated Veterinary Product Yahoo FinanceView source ↗Yahoo FinanceOct 8, 2026neutral00.6
Why Is Neogen Stock Gaining Thursday? - BenzingaWhy Is Neogen Stock Gaining Thursday? BenzingaView source ↗BenzingaOct 8, 2026neutral00.6
Neogen Corporation: Promising Recurring Demand With Food Safety - Seeking AlphaNeogen Corporation: Promising Recurring Demand With Food Safety Seeking AlphaView source ↗Seeking AlphaOct 8, 2026neutral00.6
Neogen (NEOG) Stock Grapples With Losses Despite Firmer Margins - Simply Wall StreetNeogen (NEOG) Stock Grapples With Losses Despite Firmer Margins Simply Wall StreetView source ↗Simply Wall StreetOct 7, 2026neutral00.6
New products are expected to add $100 million in revenue for food safety specialist Neogen by fiscal 2031. - Stock TitanNew products are expected to add $100 million in revenue for food safety specialist Neogen by fiscal 2031. Stock TitanView source ↗Stock TitanOct 7, 2026neutral00.6
Why Are Neogen (NEOG) Shares Soaring Today - Yahoo FinanceWhy Are Neogen (NEOG) Shares Soaring Today Yahoo FinanceView source ↗Yahoo FinanceOct 7, 2026neutral00.6
Neogen (NEOG) Securities Investigation Notice - Levi & Korsinsky - PR NewswireNeogen (NEOG) Securities Investigation Notice - Levi & Korsinsky PR NewswireView source ↗PR NewswireOct 7, 2026neutral00.6
Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key MetricsNeogen reported Q1 2026 revenue of $222.8 million, up 6.5% year-over-year, beating the consensus estimate of $208.09 million by 7.07%. EPS came in at $0.08 versus the estimate of $0.05, representing a 60% surprise. The company showed strong performance across most segments, with Food Safety revenue at $163.2 million and Animal Safety at $59.6 million, both exceeding analyst expectations. The stock has a Zacks Rank #2 (Buy) rating.View source ↗Zacks Investment ResearchOct 6, 2026bullish11
Neogen (NEOG) Q1 Earnings and Revenues Beat EstimatesNeogen reported quarterly earnings of $0.08 per share, beating consensus estimates of $0.05 and marking a 60% earnings surprise. The company also exceeded revenue expectations with $222.8 million, up from $209.19 million year-over-year. Despite strong performance, Neogen's Medical-Products industry ranks in the bottom 35% of Zacks industries. The stock has gained 86.1% year-to-date and holds a Zacks Rank #2 (Buy) rating.View source ↗Zacks Investment ResearchOct 6, 2026bullish0.3331
Neogen Stock Rallies 83% YTD: What's Driving the Surge?Neogen (NEOG) shares have surged 83% year-to-date, outperforming the S&P 500, driven by strong Food Safety segment growth with core revenue increases of 5.8% in Q4 fiscal 2026. The company is expanding manufacturing capabilities following its 3M Food Safety acquisition, planning a 50% increase in R&D spending for fiscal 2027 focused on pathogen detection and sanitation platforms. However, fiscal 2027 EPS is projected to decline 3.1% before recovering with 17.2% growth in fiscal 2028.View source ↗Zacks Investment ResearchOct 1, 2026bullish11
Neogen Stock Rallies 83% YTD: What's Driving the Surge?Neogen (NEOG) shares have surged 83% year-to-date, outperforming the S&P 500, driven by strong Food Safety segment growth with core revenue increases of 5.8% in Q4 fiscal 2026. The company is expanding manufacturing capabilities following its 3M Food Safety acquisition, planning a 50% increase in R&D spending for fiscal 2027 focused on pathogen detection and sanitation platforms. However, fiscal 2027 EPS is projected to decline 3.1% before recovering with 17.2% growth in fiscal 2028.View source ↗Zacks Investment ResearchOct 1, 2026bullish11
Neogen Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Neogen (NEOG) - PR NewswireNeogen Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Neogen (NEOG) PR NewswireView source ↗PR NewswireSep 30, 2026neutral00.6
Why Neogen (NEOG) Stock Is Falling Today - Quiver QuantitativeWhy Neogen (NEOG) Stock Is Falling Today Quiver QuantitativeView source ↗Quiver QuantitativeSep 29, 2026neutral00.6
Neogen (NEOG) Stock Trades Down, Here Is Why - Yahoo FinanceNeogen (NEOG) Stock Trades Down, Here Is Why Yahoo FinanceView source ↗Yahoo FinanceSep 29, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.